Citizens keeps Market Outperform rating on Walker & Dunlop and Rocket Lab
Citizens reiterated its Market Outperform rating, with price targets of $50 for Walker & Dunlop and $90 for Rocket Lab. Source: TradingView, citing Benzinga data.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Citizens analysts kept their Market Outperform rating on Walker & Dunlop and Rocket Lab shares. The $50 target for Walker & Dunlop implies a 50.1% upside from the October 15 close of $33.32. For Rocket Lab, the $90 target implies 62.9% upside from the $55.25 close.
According to the analysts, Walker & Dunlop's leading position in originating and servicing multifamily loans backed by federal agencies supports revenue stability. For Rocket Lab, Citizens sees a strong revenue outlook for fiscal 2027 and 2028, despite a recent delay in the Neutron launch. The information comes from TradingView, citing Benzinga.
why it matters
Rating confirmations like these appear regularly and usually move only the shares of the companies named. For the broader market they carry little weight, and a gap to price targets shows only the analyst's view, not where the stocks will trade.
tags
instruments
sources
- Citizens maintains Market Outperform rating on Walker & Dunlop, $50 price target — ru.tradingview.com, 16 October 2026 at 12:45 UTC
- Citizens maintains Market Outperform rating on Rocket Lab, $90 price target — ru.tradingview.com, 16 October 2026 at 12:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗